🇺🇸 FDA
Patent

US 9084762

T-cell immunogens derived from anti-viral proteins and methods of using same

granted A61KA61K2039/555A61K2039/572

Quick answer

US patent 9084762 (T-cell immunogens derived from anti-viral proteins and methods of using same) held by The Regents of the University of California expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/555, A61K2039/572, A61K2039/58, A61K38/08